ABSTRACT: Alteration of gene expression tightly regulates lipogenesis. Stearoyl-CoA desaturase-1 (SCD-1), a key enzyme in lipogenesis, catalyzes the conversion of SFA to MUFA, and inhibition of its activity impairs lipid synthesis. As posttranscriptional regulators, microRNAs are involved in many pathways of lipid metabolism; however, their effect on SCD-1 has not been reported. In this study, miR-125b was identified as a potential regulator of SCD-1 using bioinformatics analysis. Here, we validated SCD-1 as the target of miR-125b using a dual luciferase assay. During adipogenesis, a synthetic mimic or inhibitor was used to overexpress or reduce the expression of miR-125b in porcine adipocytes.
INTRODUCTION
Dysfunctions of adipose tissue may cause health problems in both humans (Poulos et al., 2010) and animals (German et al., 2010) . Lipogenesis is an important aspect of meat quality in farm animals (Dodson et al., 2010) . Therefore, understanding the mechanisms of regulating adipose tissue formation is important for humans and animals. Monounsaturated fatty acids are a major component of triglycerides and play an important role in lipid metabolism (Ntambi, 2004) and are converted from saturated long-chain fatty acids by stearoyl-CoA desaturase-1 (SCD). It is believed that SCD-1 plays a crucial role in lipid metabolism (Cohen et al., 2003) . Lack of SCD-1 expression in the asebia mice led to defective triglyceride synthesis (Miyazaki et al., 2000) . Higher SCD activity is strongly correlated with higher plasma triglyceride levels in humans (Attie et al., 2002) . Therefore, regulation of SCD-1 activity may represent a novel approach for regulating lipid metabolism in humans and even in animals.
Increasing data have shown that microRNAs (miRNA) are involved in regulation of adipogenesis. Interestingly, little information regarding miRNA against SCD-1 is available. In our former study, miR125b was observed to be significantly downregulated in fat-rich pigs (Lantang, a local breed in China), relative to fat-less (Landrace) pigs, in the adipose tissue (Li et al., 2012) . By contrast, the expression of SCD-1 mRNA represented a reverse tendency in 2 breeds. The results led to the hypothesis that miR-125b might play an important role in lipogenesis. Although miR-125b has been proved to regulate several genes (Akhavantabasi et al., 2012; Chaudhuri et al., 2012) , the relationship between miR-125b and SCD-1 in adipocytes remains unclear. By target scanning using TargetScan (http:// www.targetscan.org) software, SCD-1 was predicted as a potential target for miR-125b in pigs and humans. Herein, we showed that miR-125b could inhibit SCD-1 expression by targeting the 3′-untranslated region (UTR) of its mRNA, thus affecting lipogenesis and fat composition of porcine adipocytes.
MATERIALS AND METHODS

Bioinformatics Analysis
TargetScan (http://www.targetscan.org) and miRanda (http://www.microrna.org) were used to predict that miR-125b targets human SCD-1. By sequence alignment, the target site of miR-125b was identified conserved in porcine SCD-1 3′-UTR.
Ethics Statement
The animal experiments were complied with the guidelines of Guangdong Province on the Review of Welfare and Ethics of Laboratory Animals approved by the Guangdong Province Administration Office of Laboratory Animals. All procedures were conducted according to the protocol (SCAU-AEC-2010-0416) approved by the Animal Ethics Committee of South China Agricultural University.
Cell Isolation, Culture, and Differentiation
To obtain preadipocytes, postnatal Landrace pigs were killed at 5 to 7 d by exsanguination. Subcutaneous adipose tissue was isolated aseptically and rinsed in Dulbecco's modified Eagle medium/Nutrient Mixture F-12 (DMEM/F12; 1:1; GIBCO, Grand Island, NY). All visible connective tissues were removed and the tissue was minced and centrifuged at 800 × g for 5 min at 4°C and the supernatant was discarded. The remaining tissue was treated with a digestion solution containing 0.1% type-I collagenase (GIBCO) in a saline bottle for 2 h at 37°C. The digest was filtered through a 200-mesh sieve and centrifuged at 800 × g for 5 min at 4°C to discard upper mature adipocytes. Erythrocytes were lysed in lysis buffer containing 0.154 M NH 4 Cl, 10 mM KHCO 3 , and 0.1 mM EDTA for 10 min at room temperature followed by filtering through a 400-mesh sieve. Cells were then rinsed with DMEM/F12 and centrifuged at 1,500 × g for 5 min at 4°C. The preadipocytes were plated in DMEM/F12 supplemented with 10% fetal bovine serum (FBS; GIBCO) at 10% CO 2 and 37°C. To construct the subcutaneous preadipocytes differentiation model, confluent cells were maintained in adipogenic medium containing 5% FBS, 50 nM insulin, 50 nM dexamethasone, 50 μM oleate, and 0.5 mM octanoate (bovine recombinant insulin, dexamethasone, oleate, and octanoate were purchased from SigmaAldrich, St. Louis, MO) for 8 d; the medium was replaced every 2 d.
Chinese hamster ovary (CHO) cells were maintained in Roswell Park Memorial Institute medium 1640 (GIBCO) supplemented with 10% FBS.
Plasmid Construction, Transfection, and Luciferase Assay
To generate the porcine SCD-1 3′-UTR sequence containing miR-125b target site CTCAGGG, 2 singlestranded DNA were synthesized (Sangon, Shanghai, China) and annealed to form a double-stranded DNA, which contained the recognition sites of restriction enzymes XbaI and HpaI. The synthetic sequence was inserted into XbaI and HpaI enzyme-digested vector pGL3-Control (Promega Co., Madison, WI), downstream of the luciferase gene. Meanwhile, the mutagenic and deleted SCD-1 3′-UTR reporter vectors were constructed with 4 exchanged nucleotides or a deleted target site in the same way. The sequences of 3 types of 3′-UTR were as follows: SCD-1 3′-UTR (sense, ctagaACAGTCAGAATGCTCAGGGTCACTGAACCACgtt;
antisense, aacGTGGTTCAGTGACCCTGAGCATTCTGACTGTt), SCD-1 3′-UTR mut (sense, ctagaACAGTCAGAATGGTGACGCTCA CTGAACCACgtt; antisense, aacG TGGTTCAGTG AGC GTCACCATTCTG ACTGTt), and SCD-1 3′-UTR del (sense, ctagaACAGTCAGAATGTCACTGAACACgtt; antisense, aacGTG GTTCA GTGACAT TCTGACTGTt).
Chinese hamster ovary cells were seeded at a density of 2 × 10 5 cells per well in 24-well plates. When the cells reached 60 to 70% confluence, reporter vector pGL-SCD-1 3′-UTR/pGL-SCD-1 3′-UTR-mut/ pGL-SCD-1 3′-UTR-del were cotransfected with the miR-125b mimic or negative control (NC). GenEscort II (Huiji, Nanjing, China) mediated the transfection performance according to the manufacturer's protocol. Transfection efficiency was normalized by the activity of renilla luciferase expressed from a cotransfected pRL-TK vector. The luciferase assay was performed with the Dual-Luciferase reporter assay system (Promega Co.).
Transient Transfection of the miR-125b Mimic and miR-125b Inhibitor
The miR-125b mimic, miR-125b inhibitor, and negative control (NC and inhibitor negative control [iNC]) were purchased from Shanghai GenePharma Co; the sequences were as follows: miR-125b mimic (5′-UCCCUGAGACCCUAACUUGUGA-3′), miR125b inhibitor (5′-UCACAAGUUAGGGUCUCAGG GA-3′), NC (5′-UUCUCCGAACGUGUCACGUTT-3′), and iNC (5′-CAGUACUUUUGUGUAGUACAA-3′).
Preadipocytes were seeded at density of 2 × 10 5 per well in 6-well plates. When the cells reached 60 to 70% confluence, 100 pmol of miR-125b mimic or inhibitor was transfected into the cells; NC and iNC were used as NC for the miR-125b mimic and miR-125b inhibitor. Transfection was performed using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. The preadipocytes were collected after 8 d of differentiation.
Ribonucleic Acid Extraction and Real-Time Quantitative Reverse Transcription-PCR for SCD-1 and Mature miR-125b
Total RNA of differentiated adipocytes was extracted using the TRIzol reagent (Invitrogen) according to the manufacturer's protocol. Ribonucleic acid (2 μg) was digested with RNase-Free DNase I (Takara Bio Inc., Shiga, Japan) and then reverse transcribed to cDNA using Moloney murine leukemia virus reverse transcriptase (Promega Co.) with an Oligo dT18 primer for mRNA and a specific hairpin primer for the miRNA. Real-time quantitative reverse transcription-PCR was performed on an Mx3005P instrument (Stratagene, La Jolla, CA) following the manufacturer's instructions. The PCR reaction (20 μL volume) comprised 1 μL cDNA, 1.5 μM of each primer, 10 μL 2x SYBR Green PCR Master Mix (Toyobo Co., Ltd., Osaka, Japan), and water up to the total volume. The reactions were processed for 1 min at 95°C followed by 40 cycles of 15 s at 95°C, 15 s at 58°C, and 40 s at 72°C. Primers for the detection of SCD-1 and miR-125b were designed by Primer Premier 5 (PREMIER Biosoft,Palo Alto,CA) and basic local alignment search tool (BLAST) searched with the National Center for Biotechnology Information's Primer-BLAST (http://www.ncbi.nlm.nih. gov/tools/primer-blast) to confirm the specificity of the primers. β-actin and U6 were used as candidate housekeeping genes for SCD-1 and miR-125b. All primers are shown in Supplemental Table S1 (see the online version of the article at http://journalofanimalscience.org). The relative expression was calculated using the equation 2 -(ΔCt sample -Ct control) , in which CT sample is SCD-1 or miR-125b and CT control is reference gene.
Oil Red O Staining
Cells were rinsed twice with Ca 2+ -and Mg 2+ -free PBS and fixed in 4% paraformaldehyde for 30 min at room temperature. The fixed cells were stained for 1 h at temperature with Oil Red O fluid (0.5 g Oil Red O [Sigma-Aldrich] dissolved in 100 mL isopropanol [wt/ vol] , diluted in water [6:4, vol/vol] , and filtered). After staining, the cells were washed with water and photographed under a microscope.
Triglycerides Assay
The preadipocytes were seeded in 6-well plates at density of 2 × 10 5 per well. After transfection with the miR125b mimic/inhibitor and NC/iNC, as mentioned above, the cells were collected for triglycerides assay. Cells were rinsed with PBS and 150 μL of lysis buffer was added to each sample. The cells lysates were assayed for their triglycerides content using the Food Triglyceride Assay Kit (APLLYGEN, Beijing, China); total protein was detected using the BCA Protein Detection Kit (Bioteke Corporation, Beijing, China) for normalization of triglycerides concentration. The assays were performed on a microplate reader (Thermo Labsystems MK3; Thermo Fisher Scientific Inc., Waltham, MA) in 96-well plates.
Fatty Acid Composition Analysis
Differentiated adipocytes treated with the miR125b mimic/inhibitor and NC/iNC were washed with PBS and collected into 1.5-mL tubes. To each sample, 1 mL of CHCl 3 -methanol 2:1 (vol/vol) was added and the samples were placed at 4°C overnight to extract the total lipids from the cells. The supernatant was removed to a 10-mL tube and 1 mL of CHCl 3 -methanol 2:1 (vol/ vol) was added and thoroughly mixed. After drying with N 2 gas on ice, the samples were esterified by reacting them with 4 mL 0.5 N KOH-methanol at 60°C for 30 min and 3 mL 1 N H 2 SO 4 -methanol at 60°C for 30 min, in a water bath. Finally, 2 mL saturated NaCl and 0.5 mL hexane were added to each sample followed by centrifugation at 1,125 × g for 10 min at 14°C. The supernatant was stored at -20°C. One microliter of each sample was detected using a gas chromatographmass spectrometer (Finnigan trace; Thermo Electron Finnigan Co. Ltd, Waltham, MA) equipped with a 30-m DB-1 capillary column (0.25 mm i.d.). The initial column temperature (100°C) was maintained for 5 min and then raised to 200°C at 10°C/min. Finally, the temperature was raised to 220°C at 5°C/min and held for 8 min. The temperature of the injector was 220°C.
Western Blot Analysis
Proteins were extracted from the samples treated with TRIzol (Invitrogen), as previously reported (Chomczynski, 1993) . The lower organic phase was collected by discarding the upper aqueous phase and interphase. The proteins were precipitated with isopropanol at room temperature for 10 min and centrifuged at 12,000 × g for 10 min at 4°C. The samples were then rinsed with 0.3 M guanidine hydrochloride 3 times, absolute alcohol was added, and the samples were centrifuged at 7,500 × g for 5 min at 4°C. After drying, the proteins were dissolved in 1% SDS containing 1 mM phenylmethyl sulfonylfluoride. A radiometer detected the density of the protein samples (Eppendorf, Hamburg, Germany). Thirty micrograms of total proteins were separated on 10% SDS-PAGE gels and transferred onto a polyvinylidene difluoride (Millipore Corporation, Billerica, MA) membrane. The membrane was blocked with 5% skim milk and incubated with the primary antibody, polyclonal anti-SCD-1 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Images were acquired using FluorChem M (ProteinSimple, Santa Clara, CA). Protein expression was normalized by the expression of β-actin (Abcam, Cambridge, UK).
Cotransfection with a Small Interfering RNA for SCD-1 and a miR-125b Inhibitor
The small interfering RNA (siRNA) for porcine SCD-1 with NC were purchased from Shanghai GenePharm Co. The sequence of siSCD-1 was 5′-CUGUGGAGUCACCGAACUUTT-3′. After seeding adipocytes in 6-well plates, the siSCD-1/NC was cotransfected with the miR-125b inhibitor/iNC, and cells were collected for triglycerides and western blot assays.
In Vivo Tests
For overexpression of miR-125b in vivo, we constructed an expression vector for miR-125b, termed Lv-GFP-miR-125b, by inserting the synthetic pre-miR-125b sequence into pshRNA-copGFP lentivector via BamHI and EcoRI sites. Six-week-old male National Institutes of Health mice were purchased from Guangdong Province Administration Office of Laboratory Animals (Foshan, China). Hydrodynamic injection of the plasmid was performed as previously described (Liu et al., 1999) . Via tail vein injection, 100 μg of prepared vector in saline was transfected into mice, with saline and empty vector Lv-GFP as the control. The injection was completed in 5 to 8 s. Two days after the injection, the liver was dissected for frozen section preparation (Leica CM 1850 cryomicrotome; Leica Biosystems Nussloch GmbH, Nussloch, Germany) and triglycerides assay. The sections were observed and photographed using a fluorescence microscope (Leica DMIL). The triglycerides assay was performed as mentioned above.
Statistical Analysis
Data were represented as mean ± SD. Comparisons of 2 means or multiple testing were analyzed using SPSS (SPSS Inc., Chicago, IL) with Student's t test or 1-way ANOVA. Statistically significant differences were determined at P < 0.05.
RESULTS
Target Prediction of miR-125b and Verification
Using a Luciferase Report Assay
Using TargetScan (http://www.targetscan.org) and miRanda (http://www.microrna.org), miR-125b was predicted to target human for the 3′-UTR of SCD-1 (Fig. 1A) . The conserved target binding site was also found in the 3′-UTR of porcine SCD-1. The full-length 3′-UTR of SCD-1 mRNA was inserted downstream of the luciferase gene in the pGL3-Control reporter plasmid, and the seed sequence was also mutated or deleted to disrupt miR-125b binding (Fig. 1A and 1B) . The wild-type (pGL3-SCD-1 3′-UTR) or mutant (pGL3-SCD-1 3′-UTR-mut and pGL3-SCD-1 3′-UTR-del) plasmid was cotransfected with a miR-125b mimic into CHO cells together with the renilla control pRL-TK for normalization. Forty-eight hours after transfection, the luciferase activity of the miR-125b group was significantly lower than that of the NC group (P < 0.05) and the reduction was rescued in the mutation and deletion group (Fig. 1C) . Thus, SCD-1 was confirmed as the target of miR-125b.
Expression of miR-125b and SCD-1 during Porcine Preadipocytes Differentiation
To understand the expression mechanism of miR125b and SCD-1 during differentiation of preadipocytes, the preadipocytes were stimulated to become mature adipocytes using adipogenic medium for 10 d. During this process, lipid droplets were accumulated ( Fig. 2A) . Real-time quantitative reverse transcription-PCR revealed that SCD-1 expression increased in a time-dependent manner (Fig. 2B) , whereas the expression of miR-125b presented a descended tendency (Fig. 2C) .
Durability of miR-125b Mimic in Transfected Porcine Adipocytes
To ensure the effectiveness of the miR-125b mimic throughout the experimental process, we verified its persistence after transfection in porcine adipocytes. The miR-125b mimic, inhibitor, or corresponding control was transfected into preadipocytes. Compared with the control group, the level of miR-125b dramatically increased in adipocytes 8 d after mimic transfection (Fig. 3A) . By contrast, miR-125b expression was notably reduced in adipocytes (P < 0.05) relative to iNC (Fig. 3B) . These results suggested that use of the miR125b mimic is feasible and suitable for further study.
miR-125b Regulates Lipogenesis in Porcine Adipocytes
To ascertain whether miR-125b has a direct effect on lipogenesis of porcine adipocytes, the miR-125b mimic, inhibitor, or NC was transfected into preadipocytes, which were then stimulated to differentiate. After 8 d, formation of lipid droplets was observed by staining with Oil Red O. The miR-125b mimic group showed a significant decrease in lipid droplets in porcine adipocytes, and the miR-125b inhibitor rescued this decrease (Fig. 4A) . The results of the triglycerides assay further confirmed this observation. Triglycerides levels were significantly reduced in the miR-125b mimic group (P < 0.01), whereas miR-125b inhibitor significantly increased the triglycerides concentration in cells (P < 0.05; Fig. 4B ). Western blotting of total proteins from cells sampled on Day 8 showed that the miR-125b mimic significantly decreased SCD-1 protein levels (P < 0.01; Fig. 4C ). Stearic acid is a major substrate of SCD-1, and the utilization ratio of this fatty acid is a measure of the activity of SCD-1. We determined the fatty acid composition of adipocytes by gas chromatograph-mass spectrometer (Finnigan trace; Thermo Electron Finnigan Co. Ltd., Waltham, MA) after transfection with NC and miR-125b mimic and inhibitor. All compositions are shown in Supplemental  Table S2 (see the online version of the article at http:// journalofanimalscience.org). We then calculated the ratio of C18:1:C18:0. Interestingly, the miR-125b mimic significantly reduced the C18:1:C18:0 ratios (P < 0.01), and the effect was rescued by miR-125b inhibitor (Fig.  4D) . The results suggested a reduced activity of SCD-1 mediated by miR-125b and correlated with the changes in lipogenesis.
miR-125b Inhibitor Rescued Inhibitory Effect of SCD-1 Small Interfering RNA on Lipogenesis
To further confirm the direct effect of miR-125b on SCD-1, preadipocytes were transfected with different combinations of the miR-125b inhibitor and siRNA against SCD-1 and stimulated to mature into adipocytes (Fig. 5A) . After collecting cells, triglycerides were assayed and western blotting was performed to detect SCD-1 protein expression. Lipid droplets in Group 2 (iNC + siRNA) were significantly reduced relative to Group 1 (miR-125b inhibitor + siRNA NC), proving the specific inhibition of siSCD-1 on SCD-1. More interestingly, this effect was rescued by the addition of the miR-125b inhibitor (Group 3, inhibitor + siSCD-1). Accordingly, the triglycerides concentration showed the same tendency as the lipid droplets accumulated. Triglycerides levels in Group 2 were significantly reduced (P < 0.01) and triglycerides in Group 3 were significantly increased (P < 0.01; Fig. 5B ) relative to Group 1. Western blotting further confirmed the direct regulation of miR-125b on SCD-1 (Fig. 5C) . The miR-125b inhibitor rescued the inhibition of siRNA on SCD-1; therefore, it is likely that miR-125b directly regulates SCD-1.
In Vivo Validation of the Regulation of Lipid Accumulation by miR-125b
To further verify the regulation of lipogenesis by miR-125b in vivo, we injected an expression vector for miR-125b (Lv-GFP-miR-125b) into mice through the tail vein by using a hydrodynamic method. After 48 h, fluorescence appeared in the hepatic section injected with empty vector and Lv-GFP-miR-125b but not in the saline-injected group (Fig. 6A) . The results of quantitative analysis of miR-125b indicated successful expression of the foreign gene in the liver (Fig. 6B) . A liver triglycerides assay indicated that Lv-GFP-miR-125b notably downregulated the triglycerides concentration in the liver (P < 0.05) relative to the saline group and empty vector (Fig. 6C) . Consistently, the group injected with Lv-GFP-miR-125b presented decrease of SCD-1 protein content compared with other 2 groups (Fig. 6D) .
DISCUSSION
Interpreting the precise mechanisms of lipid metabolism is crucial for understanding metabolic disorders, such as obesity, atherosclerosis, and diabetes. The role of miRNA in regulating lipid metabolism has been reported. For example, miR-122 was implicated as a key regulator in cholesterol and fatty acid metabolism in the adult liver (Esau et al., 2006; Gatfield et al., 2009) , and advanced research verified that miR-370 acts on the lipid-metabolic genes by regulating the expression of miR-122 (Iliopoulos et al., 2010) . Likewise, recent work showed that hsa-miR-33a/b are presented in the intron of the sterol regulatory element-binding proteins-1/2 (SREBP-1/2) gene and regulate cholesterol homeostasis in cooperation with their host genes (FernandezHernando et al., 2011) . Other miRNA, including miR-335 (Nakanishi et al., 2009) , miR-378/378* (Gerin et al., 2010) , and miR-130 (Lee et al., 2011) , are involved in regulating cholesterol homeostasis, fatty acid metabolism, and lipogenesis (Fernandez-Hernando et al., 2011). Understanding the effects of miRNA on the regulation of lipid metabolism is beneficial for exploring the mechanisms of lipid metabolism.
SCD-1 is a rate-limiting enzyme in lipogenesis and is highly expressed in the liver and in adipose tissue. SCD-1 catalyzes the conversion of SFA to the monounsaturated form, which is component of triglycerides, wax esters, cholesterol esters, and membrane phospholipids (Flowers et al., 2006; Jiang et al., 2008; Mauvoisin and Mounier, 2011) . The ratio of SFA to MUFA is a measurement of SCD-1 activity, which correlates with SCD-1 gene expression, protein expression, and enzyme activity (Yee et al., 2012) . In SCD-1-deficient mice, lower BW and hepatic lipogenesis were observed (Miyazaki et al., 2009) , and for brown adipose tissue, insulin signaling and glycogen increased (Rahman et al., 2005) . Even in white adipose tissue, SCD-1 deficiency mediates the reduction of TNF-α expression attenuating inflammation (Liu et al., 2010) . SCD-1 has been indicated to be associated with various human diseases, of course, in addition to metabolic diseases (Savransky et al., 2008; Leamy et al., 2013) as well as other diseases, such as Alzheimer's disease (Astarita et al., 2011; Zarrouk et al., 2015) , the therapy targeting SCD-1 could have interest in these diseases. Additionally, SCD-1 is related to meat quality in cattle (Mannen, 2011) and pigs (White et al., 2009) , being related to the fatty acid composition. Therefore, we considered SCD-1 a principal agent in lipogenesis.
Previous research on SCD-1's involvement in lipogenesis was predominantly physiological, and there are no data on the effects of miRNA on SCD-1. The functions of miRNA in regulating a variety of metab- (NC, and inhibitor) . Data are shown as means ± SD (*P < 0.05, **P < 0.01, n = 5). (C) Western blot showing that SCD-1 protein expression in adipocytes was significantly decreased by miR-125b mimic versus control; data are shown as means ± SD (**P < 0.01, n = 3). (D) Fatty acid composition of adipocytes treated with miR-125b mimic or miR-125b inhibitor, as assayed by gas chromatography-mass spectrometer. The desaturation index of stearic acid was calculated to denote SCD-1 activity. The ratio of C18:1:C18:0 was reduced significantly by treatment with miR-125b mimic; the miR-125b inhibitor rescued this effect. Data are shown as means ± SD (*P < 0.05, **P < 0.01, n = 6).
olism-related genes suggest that they may serve as a novel therapy method in metabolic diseases.
Many studies showed that the expression of miR-NA was negatively related to their target genes both in animals and plants (Axtell and Bartel, 2005; Ren et al., 2009; Xin et al., 2009) , and in our former study, the negative correlation between miR-125b and SCD-1 in 2 breeds was indicated. Actually, this study also revealed the negative correlation between miR-125b and SCD-1 in differentiated adipocytes. These data as well as the target prediction further illustrated the potential target relationship between miR-125b and SCD-1. Most miRNA act by targeting the 3′-UTR of the mRNA of target genes (Lal et al., 2009; Deng et al., 2011; Kim et al., 2012) . Our luciferase assay results showed significantly decreased luciferase activity of pGL3-SCD-1 3′-UTR versus control, with no changes of pGL3-SCD-1 3′-UTR-mut and pGL3-SCD-1 3′-UTR-del, which proved that miR-125b may act on SCD-1 by targeting seed sequence in the 3′-UTR.
SCD-1 is an iron-containing enzyme that catalyzes Δ9-cis desaturation in the synthesis of fatty acid, the main product of which is palmitoleoyl-CoA and oleoyl-CoA. Higher SCD-1 activity was indicated by a higher ratio of 18:1:18:0 (Jiang, 2005) . Fatty acid composition detection in this study showed the miR-125b mimic decreased the 18:1:18:0 ratio; it is reasonable to assume that the reduction of the 18:1:18:0 ratio results from the inhibitory effect of miR-125b on SCD-1 expression. SCD-1 is also involved in the synthesis of triglycerides and cholesterol ester, a possible explanation for the requirement of SCD-1 expression in the production of more accessible MUFA (Paton and Ntambi, 2009 ). In a previous study, SCD-1-deficient mice showed reduced triglycerides synthesis (Cohen et al., 2002) . Our results showed that the miR125b mimic decreased the accumulation of triglycerides in adipocytes versus control. This was consistent with the view that SCD-1 is involved in the synthesis of triglycerides. Meanwhile, Oil Red O staining showed that lipid droplets decreased in the miR-125b mimic group and increased in the miR-125b inhibitor group.
As a critical factor in lipogenesis, the expression of SCD-1 is implicated in multiple processes. Numerous transcription factors mediate SCD-1 expression via binding to the SCD-1 promoter, such as sterol regulatory element-binding proteins-1c (SREBP-1c), liver X receptor (LXR), and peroxisome proliferators activated receptor γ coactivator-1α (PGC1-α; Paton and Ntambi, 2009; Mauvoisin and Mounier, 2011) . By contrast, the expression of SREBP-1c is disrupted in SCD-1 -/-mice (Paton and Ntambi, 2009) . In adipocytes, overexpression of miR-125b only resulted in reduced protein levels of SCD-1. The result was compatible with the original model of miRNA action (Olsen and Ambros, 1999) . It is reasonable to assume that miR-125b acts to suppress expression of SCD-1 at the protein level.
By perfect complementary to target sequences, siRNA have been widely applied to interfere with gene expression specifically (Novina et al., 2002; Mu et al., 2009 ). MicroRNAs do not act on unique genes, with its imperfect matching to 3′-UTR of target genes mRNA. With similar phenotypes, miR-21 was proved to target both transforming growth factor β (TGF-β) and signal transducers and activators of transcription-3 (STAT3; Kim et al., 2009 Kim et al., , 2012 . Therefore, the phenotypes caused by indirect action of miRNA on target genes may confuse the results. As previous report shown, cooperation of Bim siRNA and a miR-24 inhibitor demonstrated the direct correlation between Bim and miR-24 (Qian et al., 2011) . We also designed an experiment involving the combination of an SCD-1 siRNA and miR-125b inhibitor. Both the triglycerides assay and western blotting of SCD-1 in adipocytes showed that the miR-125b inhibitor rescued the specific downregulation of SCD-1 by the siRNA, which provided further evidence for the direct action of miR-125b on SCD-1. Moreover, an in vivo test in mice also showed reduced hepatic triglycerides levels resulting from injection of a miR-125b expression plasmid, which represents initial evidence for a physiological role of miR-125b in the regulation of lipogenesis in vivo, even though more evidence is required to explore this point. The CRISPR-Cas9 system mediates new type of site-specific nuclease by guiding endonuclease Cas9 to the specific location (Hsu et al., 2014; Sander and Joung, 2014) . With simple and feasible gene modification, this method has been applied in various aspects, such as the knockout of miRNA (Zhao et al., 2014; Ho et al., 2015) . More and more popular CRISPR-Cas9 system may be a good choice for further study the function of miR-125b both in cells and in vivo.
Interestingly, miR-125b was suggested to act as a posttranscriptional repressor of TNF-α (Tili et al., 2007) , which inhibited the expression of PPARγ (Giaginis et al., 2009) . Meanwhile, the expressions of adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) were suppressed by both tumor necrosis factor (TNF-α) and insulin (Kralisch et al., 2005) . Therefore, we could hypothesize that maintaining the balance of lipogenesis may be partially mediated by 2-sided regulation in lipogenesis and by regulation of adipogenic cells by miR-125b.
Along with the rise of obesity, related diseases such as diabetes, insulin resistance, and cardiovascular disease are increasing (Sampath et al., 2007) . It is reported that SCD-1 is a critical metabolic control point, and inhibition of its expression could be beneficial in the treatment of metabolic disorders (Paton and Ntambi, 2009) . As a novel therapy, miR-125b could be chosen to inhibit the expression of SCD-1. Our study verified the suppressive effect of miR-125b on SCD-1 in primary adipocytes, which may contribute to the development of novel treatments of metabolic syndrome.
In summary, this study provided a new explanation of lipid metabolism regulation by miRNA. miR125b regulates the expression of SCD-1, which affects lipogenesis and may represent a novel method of treating metabolic disorders.
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